Management of end-stage liver disease in chronic hepatitis B

Hui Hui Tan, Paul Martin

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


The consequences of chronic hepatitis B virus infection include hepatocellular carcinoma and liver cirrhosis. Effective antiviral therapy in patients with hepatitis B with advanced liver disease with viral suppression and sustained HBeAg seroconversion (where applicable) may abort hepatic decompensation, diminish hepatocellular risk, and reduce the risk of viral recurrence after transplantation. Overt hepatic decompensation is an indication for referral to a transplant center.

Original languageEnglish (US)
Pages (from-to)477-493
Number of pages17
JournalClinics in liver disease
Issue number3
StatePublished - Aug 2010


  • Antiviral therapy
  • Cirrhosis
  • End-stage liver disease
  • Hepatitis B
  • Liver transplantation

ASJC Scopus subject areas

  • Hepatology


Dive into the research topics of 'Management of end-stage liver disease in chronic hepatitis B'. Together they form a unique fingerprint.

Cite this